Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
alemtuzumab (campath) (1 trial)
Multiple Sclerosis (Phase 1)
Sclerosis (Phase 1)
Trials (1 total)
Trial APIs (1 total)